Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 5 | Mind Blowing Facts

3 Stocks That Can Help Ease Your Recession Fears

Major macroeconomic headwinds have heightened recessionary fears in the economy. Moreover, the Fed will likely keep raising rates next year as well. Amid fears of a downturn, fundamentally strong stocks PepsiCo (PEP), Humana (HUM), and Weis Markets (WMK) might be ideal investments based on their stable and consistent dividend history.…

Audits — hidden until now — reveal millions in Medicare Advantage overcharges

Newly released federal audits reveal widespread overcharges and other errors in payments to Medicare Advantage health plans for seniors, with some plans overbilling the government more than $1,000 per patient a year on average.

Tribune News Service

Hidden audits reveal millions in overcharges by Medicare Advantage plans

Hidden audits reveal millions in overcharges by Medicare Advantage plans

Taxpayers footed the bill for care that should have cost far less, according to records released under the Freedom of Information Act. The U.S. government may charge insurers $650 million as a result.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Humana Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bearish stance on Humana. Looking at options history for Humana (NYSE:HUM) we detected 13 strange trades.

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022

2 Health Insurance Stocks to Buy in October and 1 to Avoid

The raging inflation is expected to increase healthcare expenditure significantly. This, along with heightened health awareness in this post-pandemic era, should drive the demand for health insurance. So, investing in fundamentally strong health insurance stocks, UnitedHealth Group (UNH) and Humana Inc. (HUM), could be wise. On the other hand, Clover…

Top Financial Media Stories Friday, September 23: Apple Resolves iPhone 14 Pro Camera Glitch, Credit Suisse Shares Tumble As It Looks For Capital Infusion, Boeing Penalized $200M For Misleading About 737 MAX Safety And More..

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022

This Is What Whales Are Betting On Humana

This Is What Whales Are Betting On Humana

Someone with a lot of money to spend has taken a bearish stance on Humana (NYSE:HUM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

3 Stocks to Target as Investors Rotate Back Into the Health Care Sector

3 Stocks to Target as Investors Rotate Back Into the Health Care Sector

Investors seem to show renewed interest in the healthcare sector as COVID-19 cases rise worldwide and portfolio resiliency amid the uncertain macro environment. So, fundamentally strong healthcare stocks Cigna Corp (CI), Centene Corp (CNC), and Humana (HUM) might be solid buys now. Read on.

Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years

Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 11.85% on an annualized basis producing an average annual return of 18.87%. Currently, Humana has a market capitalization of $59.29 billion.

What Are Whales Doing With Humana

What Are Whales Doing With Humana

A whale with a lot of money to spend has taken a noticeably bullish stance on Humana. Looking at options history for Humana (NYSE:HUM) we detected 10 strange trades.

Where Humana Stands With Analysts

Where Humana Stands With Analysts

Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter:

How Is The Market Feeling About Humana?

How Is The Market Feeling About Humana?

Humana's (NYSE:HUM) short percent of float has risen 8.42% since its last report. The company recently reported that it has 1.29 million shares sold short, which is 1.03% of all regular shares that are available for trading.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Defensive Stocks to Outperform in this Bear Market

While the stock market has entered a bear phase following the release of multi-decade high inflation data, the health insurance industry could survive the downturn because of the near-inelastic demand for health coverage. Therefore, investors looking to dodge a market downturn could bet on fundamentally sound health insurance stocks Anthem…

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,500 Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.8% on an annualized basis producing an average annual return of 17.56%. Currently, Humana has a market capitalization of $53.98 billion.

How Is The Market Feeling About Humana?

Humana's (NYSE:HUM) short percent of float has risen 6.25% since its last report. The company recently reported that it has 1.50 million shares sold short, which is 1.19% of all regular shares that are available for trading.

HP And 3 Other Stocks Insiders Are Selling

US stocks closed sharply higher on Wednesday after the Federal Reserve raised its target fed funds rate by 0.5%. Investors, meanwhile, focused on some notable insider trades.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Medicare surprise: Drug plan prices touted during open enrollment can rise within a month

Something strange happened between the time Linda Griffith signed up for a new Medicare prescription drug plan during last fall’s enrollment period and when she tried to fill her first prescription in January.

Drug plan prices touted during Medicare open enrollment can rise within a month

Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.

If You Invested $1000 In Humana 20 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.96% on an annualized basis producing an average annual return of 17.93%. Currently, Humana has a market capitalization of $54.86 billion.

Expert Ratings for Humana

Over the past 3 months, 6 analysts have published their opinion on Humana (NYSE:HUM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Humana's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Humana (NYSE:HUM) earned $930.00 million, a 7253.85% increase from the preceding quarter. Humana also posted a total of $24.08 billion in sales, a 13.59% increase since Q4.

Humana Q1 Earnings Beats Expectations, Raises FY22 Profit Guidance

Humana Inc (NYSE:HUM) has posted Q1 adjusted sales of $24.08 billion, beating the consensus of $23.51 billion. The benefits expense ratio increased from 86.4% to 85.9%, and the operating cost ratio increased from 12% to 9.7%. Humana posted an adjusted EPS of $8.04, beating the consensus of $6.78 and $6.38 posted a…

Humana: Q1 Earnings Insights

Humana (NYSE:HUM) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

1 … 3 4 5 6

People

Kritika SarmahHer

Dipanjan BanchurSince

Chiquita BrooksLaSure

Stacie Dusetzina

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Wall Street Journal

UnitedHealthcare

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Prescription Drug

Freedom of Information Act

Places

383,881 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play